HEXO Corp. Closes US$25.0 Million Registered Direct Offering
HEXO Corp. Closes US$25.0 Million Registered Direct Offering OTTAWA, Jan. 02, 2020 (GLOBE NEWSWIRE) — HEXO Corp. (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced it has closed its previously announced registered direct offering with...
PathogenDx Announces $7.5 Million in Series B Funding
DNA-based pathogen testing company completes funding round led by Cresco Capital Partners in just three months. TUCSON, Ariz., Sept. 30, 2019 /PRNewswire/ — PathogenDx, Inc., an innovator in DNA-based pathogen testing technology for the cannabis, hemp,...
MediPharm Labs and TerrAscend Enter Major Private Label Concentrate Supply Agreement With Potential Value Up to $192 Million
MediPharm Labs to supply TerrAscend with large volumes of high-quality CBD and THC distillate Multi-Year supply agreement to support TerrAscend’s roll out of Canadian Cannabis 2.0 derivative products TORONTO, Sept. 25, 2019 (GLOBE NEWSWIRE) — MediPharm Labs...
The Ins and Outs of Automated Trading Systems
Algorithmic trading systems have numerous pros and cons for stock market traders. The benefits may outweigh the cons for investors and potentially provide the framework for steady portfolio growth. Certain aspects of automated trading remove the human element out of...